Calendar MaaT Pharma

Equities

MAAT

FR0012634822

Market Closed - Euronext Paris 06:22:07 30/04/2024 pm IST 5-day change 1st Jan Change
9.3 EUR -0.64% Intraday chart for MaaT Pharma +5.44% +33.24%

Chart calendar MaaT Pharma

bb648b7558.KTtatc2BdwhxY-Jpc-Y7rkgx3XLV5DmiV0l_KA_XvVc.SHE5wYLoKH8eV6tbQ5QC7yUF5Tfl1HXSExM4SW7v82NhDWn7jOMnZRcAgQ~e3b2a6fe7d8e2e17b7809ac0ca1b5a54

Upcoming events on MaaT Pharma

14/05/2024 Q1 2024 Sales and Revenue Release
28/05/2024 02:30 pm Annual General Meeting
11/06/2024 Portzamparc Mid & Small Caps Conference
25/06/2024 Stifel European Healthcare Summit
19/09/2024 Q2 2024 Earnings Release
05/11/2024 Q3 2024 Sales and Revenue Release
27/03/2025 Q4 2024 Earnings Release (Projected)
24/09/2025 Q2 2025 Earnings Release (Projected)
26/03/2026 Q4 2025 Earnings Release (Projected)
30/09/2026 Q2 2026 Earnings Release (Projected)

Past events on MaaT Pharma

17/04/2024 European Society for Blood and Marrow Transplantation Meeting
15/04/2024 Van Lanschot Kempen Life Sciences Conference
14/04/2024 European Bone Marrow Transplant Meeting
10/04/2024 09:30 pm American Association for Cancer Research Meeting - Abstract Number: 6687
28/03/2024 10:30 pm Q4 2023 Earnings Release
08/01/2024 Investor meeting
18/12/2023 10:30 pm Business Update Call
12/12/2023 04:30 am American Society of Hematology Meeting - Poster number: 4947
11/12/2023 04:30 am American Society of Hematology Meeting - Poster number: 3553
15/11/2023 Francophone Society of Marrow Transplantation and Cellular Therapy Congress
14/11/2023 Investor meeting
09/11/2023 11:00 pm Q3 2023 Sales and Revenue Release
01/11/2023 Society for Immunotherapy of Cancer Meeting - Abstract Number: 1321
01/11/2023 Society for Immunotherapy of Cancer Meeting - Abstract Number: 1304
09/10/2023 Investor Access Event
04/10/2023 KBC Securities Life Sciences Conference
04/10/2023 Portzamparc Biotech & Health Seminar
27/09/2023 LPB Regional Values Forum
26/09/2023 09:30 pm Q2 2023 Earnings Release
27/07/2023 09:30 pm Q2 2023 Sales and Revenue Release

Annual results

Fiscal PeriodDecember 2020 2021 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
2,14


0,97
1,20
-19%
2,23
5,00
-55.44%

4,00

EBITDA
Million EUR
Released
Forecast
Spread
0,00


-8,57
-16,1
46.8%
-19,1
-22,8
16.35%

-29,0

EBIT
Million EUR
Released
Forecast
Spread
0,00


0,00
0,00
-
-19,9
-23,1
13.67%

-29,5

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
0,00


0,00
0,00
-
-19,7
-23,3
15.38%

-29,0

Net income
Million EUR
Released
Forecast
Spread
0,00


0,00
0,00
-
-19,7
-23,3
15.38%

-29,6

EPS
EUR
Released
Forecast
Spread
-25,7


0,00
0,00
-
-1,70
-2,37
28.27%

-2,55

Announcement Date04/10/2114/04/2228/03/24-

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise